CMND

Clearmind Medicine (CMND)

Clearmind Medicine Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:CMND

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/11	05:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CMND	Clearmind Medicine Inc
2024/05/10	21:24	GlobeNewswire Inc.	Clearmind Medicine Advances its Proprietary Psychedelic- Based Synthetic Alcohol Beverage Product	NASDAQ:CMND	Clearmind Medicine Inc
2024/05/08	05:01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:CMND	Clearmind Medicine Inc
2024/05/07	20:46	GlobeNewswire Inc.	Clearmind Medicine Secures Exclusive Global Rights to Breakthrough Psychedelic Compounds for PTSD Treatment	NASDAQ:CMND	Clearmind Medicine Inc
2024/05/01	05:15	GlobeNewswire Inc.	Clearmind Applies to Cease Being a Reporting Issuer in Canada	NASDAQ:CMND	Clearmind Medicine Inc
2024/04/17	20:49	GlobeNewswire Inc.	Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders	NASDAQ:CMND	Clearmind Medicine Inc
2024/04/10	20:17	GlobeNewswire Inc.	Clearmind Medicine Files U.S. Patent Application for Psychedelic-Based Treatment for Eating Disorders	NASDAQ:CMND	Clearmind Medicine Inc
2024/04/09	21:07	GlobeNewswire Inc.	Clearmind Medicine CEO Issues Letter to Shareholders	NASDAQ:CMND	Clearmind Medicine Inc
2024/03/19	20:55	GlobeNewswire Inc.	Breakthrough in Wellness: Clearmind Medicine's Psychedelic Treatment Granted Divisional Patent Approval in China	NASDAQ:CMND	Clearmind Medicine Inc
2024/03/13	21:14	GlobeNewswire Inc.	Clearmind Medicine Obtains Clearance for its Psychedelic- Based Alcoholism Clinical Trial	NASDAQ:CMND	Clearmind Medicine Inc
2024/03/13	20:30	GlobeNewswire Inc.	Clearmind Medicine Received Approval for a Voluntary Delisting of its Common Shares From the Canadian Securities Exchange	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/27	21:58	GlobeNewswire Inc.	Clearmind Medicine Submits Three Additional International Patent Applications for Innovative MDMA, Ibogaine and Ketamine Compounds	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/27	21:58	GlobeNewswire Inc.	SciSparc-Clearmind Partnership Yields Three New International Patent Applications for MDMA, Ibogaine and Ketamine Compounds	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/23	21:06	GlobeNewswire Inc.	Clearmind Medicine Receives Approval to Commence its Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/20	21:14	GlobeNewswire Inc.	SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/20	21:14	GlobeNewswire Inc.	Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/05	21:51	GlobeNewswire Inc.	Clearmind Medicine Receives Patent Approval for its Psychedelic Based Treatment of Binge Behaviors in China	NASDAQ:CMND	Clearmind Medicine Inc
2024/02/01	22:15	GlobeNewswire Inc.	Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center	NASDAQ:CMND	Clearmind Medicine Inc
2024/01/17	01:19	GlobeNewswire Inc.	Clearmind Medicine Inc. Closes US$2.4 Million Registered Direct and Private Placement	NASDAQ:CMND	Clearmind Medicine Inc
2024/01/11	23:28	GlobeNewswire Inc.	Clearmind Medicine Inc. Announces Pricing of $2.4 Million Registered Direct and Private Placement	NASDAQ:CMND	Clearmind Medicine Inc
2024/01/10	21:18	GlobeNewswire Inc.	Clearmind Medicine Completed Type A Meeting with the FDA	NASDAQ:CMND	Clearmind Medicine Inc
2024/01/04	21:18	GlobeNewswire Inc.	SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments	NASDAQ:CMND	Clearmind Medicine Inc
2024/01/04	21:18	GlobeNewswire Inc.	Clearmind Medicine and SciSparc Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic- Based Treatments	NASDAQ:CMND	Clearmind Medicine Inc
2023/12/14	22:26	GlobeNewswire Inc.	Clearmind Medicine Announces It Is In Compliance with All Applicable Nasdaq Listing Standards	NASDAQ:CMND	Clearmind Medicine Inc
2023/12/05	22:47	GlobeNewswire Inc.	Clearmind Medicine Achieved Positive Results in Cocaine Addiction Treatment	NASDAQ:CMND	Clearmind Medicine Inc
2023/12/01	22:14	GlobeNewswire Inc.	Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial	NASDAQ:CMND	Clearmind Medicine Inc
2023/11/28	22:25	GlobeNewswire Inc.	Clearmind Medicine Announces Positive Results from its Weight Loss and Metabolic Disorder Program with its Proprietary Psychedelic- Based Treatment	NASDAQ:CMND	Clearmind Medicine Inc
2023/11/27	22:55	GlobeNewswire Inc.	Clearmind Medicine to Participate in Traditional vs. Novel Psychedelics Virtual Event with Leading Industry Figures	NASDAQ:CMND	Clearmind Medicine Inc
2023/11/21	22:15	GlobeNewswire Inc.	Clearmind Medicine Announces 1-for-30 Reverse Share Split	NASDAQ:CMND	Clearmind Medicine Inc
2023/11/18	06:15	GlobeNewswire Inc.	Clearmind Medicine Announces Receipt of Nasdaq Delisting Notice and Plan for Immediate Recompliance	NASDAQ:CMND	Clearmind Medicine Inc